Brief: Tracon Pharmaceuticals Submits Request For Appeal Hearing Before Nasdaq Panel
19/12/2023 23:25
Dec 19 (Reuters) - TRACON Pharmaceuticals Inc TCON.O :
* TRACON PHARMACEUTICALS- ON DEC 12, SUBMITTED REQUEST FOR
ORAL
APPEAL HEARING BEFORE NASDAQ PANEL, HEARING IS SCHEDULED TO
OCCUR ON MAR 7, 2024
Further company coverage: TCON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants